Italy

 

Low key Latvia sale kicks off Orpea refocusing

Last week, French nursing home operator Orpea initiated the start of the partial sale of its €1.2bn real estate portfolio, commencing with its Latvian presence - a singular retirement home in Riva. This low key sale marks the first small step in a major three-year plan to refocus its geographies. HBI speaks to a market expert to find out more.

Interview: Stephane Pichon, Your Care Consult

HBI catches up with Stephane Pichon ahead of the Investing in Health Care Property panel at HBI 2023, to discuss the dramatic changes of the past year and how this has impacted health care real estate investment, and the long term outlook for the health care sector.

Is Kursana a Cinderella?

Dussmann, the big European facilities management company which also owns Kursana, the fifth largest German nursing home group, saw revenue grow 20% to €2.8 billion in 2022. The company claimed that this was “almost exclusively organic.” But the Care & Kids division which is mainly Kursana didn’t grow at all. Is it a Cinderella?

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Inflow of nurses to top five European markets

This week, HBI looks at the annual inflow of nurses from abroad to the big five Western European markets - the United Kingdom, Germany, France, Italy, and Spain - using public data from OECD. Those looking for an outlier need look no further than the UK.

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Find Us